| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/28/1993 | US5248603 Superoxide dismutase |
| 09/28/1993 | US5248507 Hypertonic isochloremic formulation for circulatory shock |
| 09/28/1993 | US5248499 Control of microbial infections in transplant patients |
| 09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
| 09/28/1993 | CA2092766A1 Steroid derivatives |
| 09/28/1993 | CA2092729A1 Method for inducing immunosuppression |
| 09/28/1993 | CA1322521C Thyrotropin-releasing hormone analog composition and use thereof |
| 09/23/1993 | DE4208923A1 Antirheumatic and antiinflammatory agent - comprising mixt. cpds. contg. aminoacid(s), isolated from bacteria or plants, esp. Helleborus, with long lasting action at low doses |
| 09/23/1993 | DE4208634A1 DNA and poly:peptide(s) encoding the pheromone aphrodisine - used in potency and fertility treatment |
| 09/22/1993 | EP0561639A1 Cyclic peptide antifungal agents and process for preparation thereof |
| 09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |
| 09/22/1993 | EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors |
| 09/22/1993 | EP0561429A1 Method of preparing crystalline GM-CSF |
| 09/22/1993 | EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides |
| 09/22/1993 | EP0561412A1 Parathyroid hormone derivatives |
| 09/22/1993 | EP0561330A1 Topical insulin preparation |
| 09/22/1993 | EP0561303A2 Conjugates of phenylalanine-glycine with antitumor substances |
| 09/22/1993 | EP0561297A2 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/22/1993 | EP0561245A1 Blood substitutes comprising recombinant hemoglobin |
| 09/22/1993 | EP0561194A2 Anti-feline calicivirus recombinant antibody and gene fragment encoding the same |
| 09/22/1993 | EP0561183A1 Anti-ganglioside monoclonal antibody, its preparation and use as a tumour therapeutic agent |
| 09/22/1993 | EP0561172A1 Recombinant DNA Clone Encoding Laminin Receptor |
| 09/22/1993 | EP0561130A1 Stabilized biologically active polypeptide and use thereof |
| 09/22/1993 | EP0560998A1 Medicine for preventing and treating bleeding tendency |
| 09/22/1993 | EP0560969A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/22/1993 | EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 09/22/1993 | EP0560924A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 09/22/1993 | EP0560913A1 Bifunctional inhibitors of thrombin and platelet activation |
| 09/22/1993 | EP0560809A1 Agent for reducing the growth of, or removing, human body hair. |
| 09/22/1993 | EP0382842B1 Nootropic |
| 09/22/1993 | CN1076453A Novel cyclosporins |
| 09/22/1993 | CN1076358A Methods and compositions for reducing multi-drug resistance |
| 09/21/1993 | US5247070 N-terminal muteins of tumor necrosis factor |
| 09/21/1993 | US5247069 Ligands and methods for augmenting B-cell proliferation |
| 09/21/1993 | US5246921 Method for treating leukemias |
| 09/21/1993 | US5246920 Treatment of hyperprolactinemia |
| 09/21/1993 | US5246850 Increased half-life; vascular diseases; myocardial infarction |
| 09/21/1993 | US5246847 Antiinflammatory |
| 09/21/1993 | US5246830 Enzymatic process for the determination of β-lactam antibiotics |
| 09/21/1993 | US5246715 Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| 09/21/1993 | US5246701 Antiallergens |
| 09/21/1993 | US5246700 In patients suffering from malignant tumors, interleukin-4 |
| 09/21/1993 | US5246699 Maturation of hemopoietic cells |
| 09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
| 09/21/1993 | CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci |
| 09/21/1993 | CA1322331C Galenical formulations |
| 09/21/1993 | CA1322330C Nasal solutions comprising human calcitonin |
| 09/21/1993 | CA1322329C Somatotropin prolonged release |
| 09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
| 09/20/1993 | CA2091971A1 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/19/1993 | WO1993018763A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 09/16/1993 | WO1993018406A1 Assay for adrenal autoantigen |
| 09/16/1993 | WO1993018185A1 Receptor internalization signals |
| 09/16/1993 | WO1993018165A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | WO1993018163A2 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | WO1993018162A1 Pathogen-targeted biocatalyst |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018160A1 Anti-viral fusion peptides |
| 09/16/1993 | WO1993018159A2 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 09/16/1993 | WO1993018156A1 Endothelial nitric oxide synthase |
| 09/16/1993 | WO1993018153A1 Vaccinia virus b15r used in interleukin b1-involving condition |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018148A2 Tumor necrosis factor with modified channel activity |
| 09/16/1993 | WO1993018147A1 Protein compound capable of inhibiting tumoral growth |
| 09/16/1993 | WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | WO1993018141A1 Thrombin receptor antagonists |
| 09/16/1993 | WO1993018066A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | WO1993018065A1 Physiologically active proteinaceous substance |
| 09/16/1993 | WO1993018064A1 Endothelial cell-derived differentiation modulating factors, their preparation and use |
| 09/16/1993 | WO1993018062A1 Peptide which inhibits phospholipase c |
| 09/16/1993 | WO1993018061A1 Immunostimulatory agent |
| 09/16/1993 | WO1993018060A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof |
| 09/16/1993 | WO1993018059A2 L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy |
| 09/16/1993 | WO1993018058A1 Peptides mimics useful as platelet aggregation inhibitors |
| 09/16/1993 | WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
| 09/16/1993 | WO1993018056A1 Isosteric antiherpes peptide derivatives |
| 09/16/1993 | WO1993018055A2 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 09/16/1993 | WO1993018047A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017708A1 Method for treating macrophage pathogen infections |
| 09/16/1993 | WO1993017707A1 In vivo binding pair pretargeting |
| 09/16/1993 | WO1993017703A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | WO1993017701A1 Endothelin receptor-binding peptides |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017699A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | WO1993017698A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | WO1993017696A1 Method for kidney tubulogenesis |
| 09/16/1993 | WO1993017694A1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease |
| 09/16/1993 | WO1993017691A2 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease |
| 09/16/1993 | WO1993017685A1 Combinations of ace inhibitors and diuretics |
| 09/16/1993 | WO1993017670A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | WO1993017669A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 09/16/1993 | WO1993017668A1 Controlled release acth containing microspheres |
| 09/16/1993 | WO1993017581A1 A method for removing phenylalanine from proteinaceous compositions, a product so obtained and use thereof |
| 09/16/1993 | WO1993017108A3 Analogous peptides of the internal image of a viral protein |
| 09/16/1993 | WO1993016100A3 Calmodulin-binding peptides |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |